GSK Profit, Sales Beat Views; Backs Outlook
Wall Street Journal
GSK confirmed its 2023 guidance after it reported first-quarter net profit and sales above expectations but that declined on year due to lower sales of Covid-19 treatments.
Understanding current events through the lenses of the past and future.
Wall Street Journal
GSK confirmed its 2023 guidance after it reported first-quarter net profit and sales above expectations but that declined on year due to lower sales of Covid-19 treatments.